Showing results (1-10 of 125) with videos related to
Sort By:
Pageof 13
Artificial Organs|December 1, 1995
The effects and pharmacokinetics of rhG-CSF in patients with chronic renal failureT Akizawa, K Shishido, S KoshikawaArtificial Organs|February 1, 1981
Plasma beta-thromboglobulin levels in chronic renal failure patientsT Akizawa, H Nishiyama, S KoshikawaASAIO Transactions|July 1, 1991
Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysisT Akizawa, E Kinugasa, S KoshikawaNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Effects of membrane characteristics on cytokine production by mononuclear cells in regular haemodialysis patientsK Kino, T Akizawa, S KoshikawaArtificial Organs|February 1, 1988
Evaluation of beta 2-microglobulin removal with high-performance hemodiafiltrationE Kinugasa, T Akizawa, T Kitaoka, et al.Current Opinion in Nephrology and Hypertension|July 1, 1993
Recent progress in management of secondary hyperparathyroidism of chronic renal failureT Akizawa, M Fukagawa, S Koshikawa, et al.Nihon Jinzo Gakkai Shi|October 1, 1991
[The effects and pharmacokinetics of rhG-CSF on the treatment of neutropenia in patients with renal failure]K Shishido, K Niikura, T Akizawa, et al.Kidney International. Supplement|June 1, 1993
Role of uremic and endothelial factors in the development of beta 2-microglobulin amyloidosisY Nakashima, T Akizawa, T Nagai, et al.Clinical Nephrology|November 1, 1995
Plasma bradykinin levels during hemodialysis with PAN DX and polysulfone membranes with and without concurrent ACE inhibitorM Wakasa, T Akizawa, E Kinugasa, et al.Nephron|January 1, 1991
Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patientsT Akizawa, E Kinugasa, T Kitaoka, et al.Pageof 13